285 related articles for article (PubMed ID: 11782366)
1. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
Van Vleet TR; Macé K; Coulombe RA
Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
[TBL] [Abstract][Full Text] [Related]
3. Aflatoxin B1 alters the expression of p53 in cytochrome P450-expressing human lung cells.
Van Vleet TR; Watterson TL; Klein PJ; Coulombe RA
Toxicol Sci; 2006 Feb; 89(2):399-407. PubMed ID: 16280384
[TBL] [Abstract][Full Text] [Related]
4. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
5. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B(1).
Klein PJ; Buckner R; Kelly J; Coulombe RA
Toxicol Appl Pharmacol; 2000 May; 165(1):45-52. PubMed ID: 10814552
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2001 Aug; 63(7):525-40. PubMed ID: 11497333
[TBL] [Abstract][Full Text] [Related]
7. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
Yang XJ; Lu HY; Li ZY; Bian Q; Qiu LL; Li Z; Liu Q; Li J; Wang X; Wang SL
Toxicology; 2012 Oct; 300(3):138-48. PubMed ID: 22743290
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 activation in human lung.
Kelly JD; Eaton DL; Guengerich FP; Coulombe RA
Toxicol Appl Pharmacol; 1997 May; 144(1):88-95. PubMed ID: 9169073
[TBL] [Abstract][Full Text] [Related]
10. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
[TBL] [Abstract][Full Text] [Related]
11. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2.
Macé K; Gonzalez FJ; McConnell IR; Garner RC; Avanti O; Harris CC; Pfeifer AM
Mol Carcinog; 1994 Oct; 11(2):65-73. PubMed ID: 7916994
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays.
Guo Y; Breeden LL; Fan W; Zhao LP; Eaton DL; Zarbl H
Mutat Res; 2006 Jan; 593(1-2):121-42. PubMed ID: 16122766
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
16. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
Guarisco JA; Hall JO; Coulombe RA
Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
[TBL] [Abstract][Full Text] [Related]
19. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
